21 hrs ago
India Auto News
Royal Enfield sales growth and VECV operations in Q1 2013
Eicher Motors Limited has announced their financial results for the first quarter January to March 2013.
PA Office of Attorney General Press R...
Ranbaxy agrees to pay $500 million to resolve adulterated drugs claims
Attorney General Kathleen G. Kane announced today that Pennsylvania has joined with other states and the federal government in a $500 million settlement to resolve civil and criminal allegations that Ranbaxy, a pharmaceutical manufacturer based in India, introduced adulterated drugs into interstate commerce.
Ranbaxy Pleads Guilty to Manufacturing Adulterated Drugs
In the largest US generic drug safety settlement ever, Ranbaxy USA has agreed to pay $500m after pleading guilty to manufacturing and distributing adulterated drugs, according to the US Justice Department settlement agreement .
Fraud Settlement at Ranbaxy Set to Spur Exports: Corporate India
Ranbaxy Laboratories Ltd. , the Indian drugmaker whose exports to the U.S. were restricted after a fraud investigation, may revive sales to its biggest market after resolving the charges that it sold adulterated medication.
The Washington Post
Ranbaxy to Pay $500 Million to Settle Criminal, Civil Cases
Ranbaxy Laboratories Ltd. agreed to pay $500 million to resolve fraud allegations made in a whistle- blower's lawsuit and federal criminal charges that the company sold adulterated drugs while lying about it to U.S. regulators.